Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leihua Liu

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Molecular Cancer Therapeutics|June 16, 2011
Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitorsWenle Xia, Zuguo Liu, Rongrong Zong, et al.
Plos One|September 2, 2016
X-Ray Psoralen Activated Cancer Therapy (X-PACT)Mark Oldham, Paul Yoon, Zak Fathi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2005
Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignanciesNeil L Spector, Wenle Xia, Howard Burris, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Molecular Cancer Therapeutics|June 16, 2011
Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitorsWenle Xia, Zuguo Liu, Rongrong Zong, et al.
Plos One|September 2, 2016
X-Ray Psoralen Activated Cancer Therapy (X-PACT)Mark Oldham, Paul Yoon, Zak Fathi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2005
Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignanciesNeil L Spector, Wenle Xia, Howard Burris, et al.
Pageof 2